Neurovascular Care Leader CERENOVUS is positioned as an emerging leader in neurovascular care, offering a broad portfolio of devices for stroke treatment. This expertise presents a unique opportunity for collaboration with healthcare providers seeking innovative solutions for stroke management.
Industry Comparison When compared to similar companies like RapidAI, Vesalio, and Penumbra, CERENOVUS stands out in terms of employee strength and revenue potential. Leveraging this comparative advantage can be instrumental in targeting clients looking for established players in the medical equipment manufacturing sector.
Financial Stability With a revenue range of $100M - 1B, CERENOVUS demonstrates a strong financial foundation within the medical equipment industry. Utilizing this stability as a selling point can instill confidence in potential clients seeking reliable partners for long-term collaborations.
Cutting-Edge Technology By utilizing tech tools like Amazon Web Services, Google Hangouts, and Zoom, CERENOVUS showcases a commitment to leveraging advanced technologies. Highlighting this tech-driven approach can appeal to modern healthcare facilities looking for innovative solutions.
Employee Engagement With a workforce of 501-1000 employees, CERENOVUS has a dedicated team capable of providing excellent customer support and service. Emphasizing this engaged workforce in sales pitches can convey a culture of reliability and customer-centric focus to potential clients.
253
$10M$50M
310$10M$50M
32$10M
93K$1B
31$10M
39
18K$1B
43K$1B
47K$1BCERENOVUS uses 8 technology products and services including Facebook Pixel, Neptune, Adobe InDesign, and more. Explore CERENOVUS's tech stack below.
| CERENOVUS Email Formats | Percentage |
| FLast@its.jnj.com | 62% |
| LFirst@its.jnj.com | 6% |
| First.Last@its.jnj.com | 5% |
| F-Last@its.jnj.com | 3% |
| FirstLast@its.jnj.com | 2% |
| FiLast@its.jnj.com | 1% |
| LastFir@its.jnj.com | 2% |
| LastFirst@its.jnj.com | 1% |
| First_Last@its.jnj.com | 1% |
| First-Last@its.jnj.com | 2% |
| Last.First@its.jnj.com | 1% |
| FirLast@its.jnj.com | 1% |
| Last_First@its.jnj.com | 1% |
| LastF@its.jnj.com | 2% |
| LastFi@its.jnj.com | 1% |
| FirstL@its.jnj.com | 1% |
| F.Last@its.jnj.com | 1% |
| F_Last@its.jnj.com | 1% |
| FirstLa@its.jnj.com | 1% |
| FMLast@its.jnj.com | 1% |
| First.L@its.jnj.com | 1% |
| FL@its.jnj.com | 1% |
| FirstMiddleLas@its.jnj.com | 1% |
| LF@its.jnj.com | 1% |
| First.Last@jnj.com | 70% |
| FLast@jnj.com | 19% |
| Last@jnj.com | 6% |
| First@jnj.com | 5% |
Medical Equipment ManufacturingCalifornia, United States501-1000 Employees
CERENOVUS, part of Johnson & Johnson MedTech, is an emerging leader in neurovascular care. Our commitment to changing the trajectory of stroke is inspired by our long heritage and dedication to helping physicians protect people from a lifetime of hardship. CERENOVUS offers a broad portfolio of devices used in the endovascular treatment of hemorrhagic and ischemic stroke.
Company Overview
Funding & FinancialsCERENOVUS's revenue is in the range of $100M$1B
Funding & FinancialsCERENOVUS's revenue is in the range of $100M$1B
1-888-653-2347 
support@leadiq.com